Longitudinal determination of serum placental protein 13 during development of preeclampsia

Fetal Diagnosis and Therapy

Volumn 24, Issue 3, 2008, Pages 230-236

  Huppertz, Berthold ^a   Sammar, Marei ^b   Chefetz, Ilana ^b   Neumaier Wagner, Peruka ^c   Bartz, Clemens ^d   Meiri, Hamutal ^b  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b Diagnostic Technologies Ltd   (Israel)

^c UNIVERSITY OF MUNICH   (Germany)

^d RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Marker; Maternal serum; Placenta; Placental protein 13; Prediction; Preeclampsia

Indexed keywords

PLACENTAL PROTEIN 13; SOMATOMEDIN BINDING PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PREECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; FEMALE; GALECTINS; HUMANS; IMMUNOHISTOCHEMISTRY; LONGITUDINAL STUDIES; MIDDLE AGED; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY PROTEINS; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PREGNANCY TRIMESTER, THIRD; PROSPECTIVE STUDIES;

EID: 50049108374     PISSN: 10153837     EISSN: None     Source Type: Journal    
DOI: 10.1159/000151344     Document Type: Article

References (25)

1. National Collaborating Centre for Women's and Children's Health: Antenatal Care: Routine Care for the Healthy Pregnant Woman. London, National Institute for Clinical Excellence, 2003.
2. The National Institute for Clinical Excellence, Scottish Executive Health Department; Department of Health, Social Services and Public Safety, Northern Ireland: The Fifth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom 1997-1999. London, RCOG Press, 2001, pp 76-93.
3. von Dadelszen P, Magee LA, Roberts JM: Subclassification of preeclampsia. Hypertens Pregnancy 2003;22:143-148.
4. Redman CW, Sargent IL: Latest advances in understanding preeclampsia. Science 2005;308:1592-1594.
5. Sibai BM, Caritis SN, Thom E, Klebanoff M, McNellis D, Rocco L, Paul RH, Romero R, Witter F, Rosen M, Depp R, National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units: Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. N Engl J Med 1993;329:1213-1218.
6. Poston L, Briley AL, Seed PT, Kelly FJ, Shennan AH, Vitamins in Pre-eclampsia (VIP) Trial Consortium: Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial. Lancet 2006;367:1145-1154.
7. Rumbold AR, Crowther CA, Haslam RR, Dekker GA, Robinson JS, ACTS Study Group: Vitamins C and E and the risks of preeclampsia and perinatal complications. N Engl J Med 2006;354:1796-1806.
8. Than NG, Sumegi B, Than GN, Berente Z, Bohn H: Isolation and sequence analysis of a cDNA encoding human placental tissue protein 13 (PP13), a new lysophospholipase, homologue of human eosinophil Charcot-Leyden crystal protein. Placenta 1999;20:703-710.
9. Burger O, Pick E, Zwickel J, Klayman M, Meiri H, Slotky R, Mandel S, Rabinovitch L, Paltieli Y, Admon A, Gonen R: Placental protein 13 (PP-13): effects on cultured trophoblasts, and its detection in human body fluids in normal and pathological pregnancies. Placenta 2004;25:608-622.
10. Nicolaides KH, Bindra R, Turan OM, Chefetz I, Sammar M, Meiri H, Tal J, Cuckle HS: A novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound. Ultrasound Obstet Gynecol 2006;27:13-17.
11. Spencer K, Cowans NJ, Chefetz I, Tal J, Meiri H: First-trimester maternal serum PP-13, PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of pre-eclampsia. Ultrasound Obstet Gynecol 2007;29:128-134.
12. National Medical Research Council: Clinical Practice Guidelines: Management of Pre-term Labour. Singapore, Ministry of Health, 2001, pp 1-22.
13. Brown MA, Lindheimer MD, de Swiet M, van Assche A, Moutquin JM: The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001;20:IX-XIV.
14. Davey DA, MacGillivray I: The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 1988;158:892-898.
15. Knight M, Redman CW, Linton EA, Sargent IL: Shedding of syncytiotrophoblast microvilli into the maternal circulation in pre-eclamptic pregnancies. Br J Obstet Gynaecol 1998;105:632-640.
16. Jauniaux E, Watson AL, Hempstock J, Bao YP, Skepper JN, Burton GJ: Onset of maternal arterial blood flow and placental oxidative stress: a possible factor in human early pregnancy failure. Am J Pathol 2000;157:2111-2122.
17. Mayhew TM, Barker BL: Villous trophoblast: morphometric perspectives on growth, differentiation, turnover and deposition of fibrin-type fibrinoid during gestation. Placenta 2001;22:628-638.
18. Wright DE, Bradbury I: Repeated measures screening for Down's syndrome. Br J Obstet Gynaecol 2005;12:80-83.
19. Baumann MU, Bersinger NA, Surbek DV: Serum markers for predicting pre-eclampsia. Mol Aspects Med 2007;28:227-244.
20. Papageorghiou AT, Leslie K: Uterine artery Doppler in the prediction of adverse pregnancy outcome. Curr Opin Obstet Gynecol 2007;19:103-109.
21. Allaire AD, Ballenger KA, Wells SR, McMahon MJ, Lessey BA: Placental apoptosis in preeclampsia. Obstet Gynecol 2000;96:271-276.
22. Chung EY, Kim SJ, Ma XJ: Regulation of cytokine production during phagocytosis of apoptotic cells. Cell Res 2006;16:154-161.
23. Smith SC, Baker PN, Symonds EM: Increased placental apoptosis in intrauterine growth restriction. Am J Obstet Gynecol 1997;177:1395-1401.
24. Huppertz B, Kingdom JC: Apoptosis in the trophoblast - role of apoptosis in placental morphogenesis. J Soc Gynecol Investig 2004;11:353-362.
25. Goswami D, Tannetta DS, Magee LA, Fuchisawa A, Redman CW, Sargent IL, von Dadelszen P: Excess syncytiotrophoblast microparticle shedding is a feature of early-onset pre-eclampsia, but not normotensive intrauterine growth restriction. Placenta 2006;27:56-61.